Bing

SEARCH HISTORY

Eli Lilly (LLY), a steady grower if there ever was one, just went bonkers to the upside. The stock is up some 16% in the past month, which is quite uncharacteristic given its typical demeanor. Longtime followers of the …
Investor Place · ByTyler Craig · 6/25/2015
LLY stock
At Stock Options Channel, our YieldBoost formula has looked up and down the LLY options chain for the new September 18th contracts and identified one put and one call contract of particular interest. The put contract …
Forbes · 6/22/2015
Call Options
NEW YORK (TheStreet) -- Shares of Eli Lilly and Co (LLY - Get Report) are up 0.38% to $85.13 in early market trading Friday, after the pharmaceutical company had its price target raised to $92 from $77 by analysts at …
The Street · 6/26/2015
More from Bing News
Piper Jaffray reissued their overweight rating on shares of Eli Lilly and (NYSE:LLY) in a research note released on Thursday morning, AnalystRatingsNetwork.com reports. They currently have a $102.00 target price on the stock, up from their previous target ...
wkrb13.com · 14 hours ago
Eli Lilly
Eli Lilly and (NYSE:LLY)‘s stock had its “overweight” rating reaffirmed by equities researchers at Piper Jaffray in a research report issued on Thursday, MarketBeat reports. They currently have a $102.00 price target on the stock, up from their ...
Ticker Report · 7/3/2015
“Safety profile remains favorable. While we are not changing our long-term Hold on LLY, we could see some near-term upward momentum in the stock as constructive data could create significant media and investor …
bidnessetc.com · 6/26/2015
Eli Lilly and (NYSE:LLY)‘s stock had its “outperform” rating restated by Leerink Swann in a research note issued on Thursday. They currently have a $77.00 price target on the stock. Leerink Swann’s price objective points to a potential downside of ...
sleekmoney.com · 6/25/2015
NEW YORK (TheStreet) -- Eli Lilly stock had its price target raised to $92 from $77 at Leerink which maintained its "outperform" rating. "We increased our price target based on our analysis of evacetrapib's chances of success, and raised forecasts for ...
Finanzen · 6/29/2015
(RTTNews.com) - Eli Lilly & Co. ( LLY) announced Thursday morning that the Court of Appeal ... Shares are now up 4.03 at $86.29 on above average volume. The stock has risen to a 2-week high and is approaching the …
NASDAQ · 6/25/2015
LLY is up $3.66 at $85.92 on heavy volume. Midway through trading Thursday, 6.07 million shares of Eli Lilly & Co. have exchanged hands as compared to its average daily volume of 5.60 million shares. The stock has …
Wall Street Pit · 6/25/2015
shares

Eli Lilly and Company

Company
Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in t…
Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Their products are sold in approximately 125 countries. The company was founded in 1876 by Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War, after whom the company was named.
Data from: Wikipedia · Freebase